Skip to content
BidBenchmark
PresolicitationAmendment 2

6505--Dutasteride Capsules

NAC PHARMACEUTICALS (36E797)

Response status

Historical record

Jul 7, 2026, 7:30 PM UTC

This notice is no longer open.

Posted
Jun 16, 2026
Archive date
Oct 14, 2026
SAM status
Active
This is a preserved solicitation record. The response window is closed because the published deadline passed.

Answer-first brief

What the source record says

  • NAC PHARMACEUTICALS (36E797) published this presolicitation.
  • The notice uses NAICS 325412 (Pharmaceutical Preparation Manufacturing).

Procurement identity

Notice ID
4e4631a12d0141ba870f54a6cb97aca9
Solicitation
36E79726R0029
Base type
Presolicitation
Version
2 of 2

Solicitation facts

Structured fields from the current SAM notice version. A dash means the source did not publish a value.

Notice type
Presolicitation
Solicitation number
36E79726R0029
Set-aside
Set-aside code
Posted
Jun 16, 2026
Responses due
Jul 7, 2026, 7:30 PM UTC
Archive date
Oct 14, 2026
Archive type
autocustom
Base type
Presolicitation
Organization type
OFFICE
Benchmark category
Category confidence
Category source
Last seen
Aug 29, 2026

Buyer and place

Office hierarchy and place of performance as published.

Department
VETERANS AFFAIRS, DEPARTMENT OF
Department code
Subagency
VETERANS AFFAIRS, DEPARTMENT OF
Subagency code
Office
NAC PHARMACEUTICALS (36E797)
Organization path
Organization path codes
Office address
HINES, IL, 60141, USA
Place of performance
City code
State
State code
Postal code
Country

Points of contact

Contact details from the current notice version.

Notice description

Source text reproduced without an AI summary.

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0029 for an unrestricted procurement for Dutasteride Capsules, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 and 2, 30 and 90 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0029 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about June 22, 2026, with a tentative closing date of July 7, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Richard Mahario. Questions can be e-mailed to Richard.Mahario@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 Dutasteride 0.5MG Capsules 30 3,912 2 Dutasteride 0.5MG Capsules 90 25,502

Comparable award range

Historical award values for work matched by the fixed rubric—not an estimate of this opportunity.

No past awards scored highly enough to form a comparable range.

Comparable awards

The match score is decomposed so each comparison can be challenged.

No comparable awards are attached to this notice.

Amendment history

A version is preserved whenever the normalized notice contents change.

VersionNotice typeObservedResponses dueContent hash
1PresolicitationAug 10, 2026Jul 7, 2026, 7:30 PM UTC207657c17ebe2cbc
2PresolicitationAug 28, 2026Jul 7, 2026, 7:30 PM UTC48f22f523c3052ba

Record provenance

Field-level lineage for the current opportunity version.

FieldSourceSource as ofParserTransform
agency_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_dateSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
base_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
contactsSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
descriptionSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
naics_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_idSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_citySAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_country_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_postal_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_state_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
organization_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
posted_dateSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
psc_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
response_deadlineSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
sam_urlSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
solicitation_numberSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
subagency_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
titleSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
upstream_activeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

  1. 1Notice fields come from the SAM.gov contract opportunities record last seen Aug 29, 2026. SAM.gov remains authoritative.

Note 1 covers the solicitation record. No synthetic FAQ or inferred solicitation value is published.

6505--Dutasteride Capsules — federal contract opportunity · BidBenchmark